跳至主要内容
临床试验/NL-OMON45647
NL-OMON45647招募中不适用

A pilot study to determine the feasibility of Stereotactic Body Radiation Therapy following Chemotherapy for Unresectable perihilar CholangioCarcinoma - the STRONG trial

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 0 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Patients diagnosed with perihilar cholangiocarcinoma according to the criteria of the Mayo Clinic:
  • -Positive or strongly suspicious intraluminal brush or biopsy or,
  • -A radiographic malignant appearing stricture plus either:
  • -CA 19-9>100 U/ml in the absence of acute bacterial cholangitis, or
  • -polysomy on FISH, or
  • -a well-defined mass on cross sectional imaging
  • -One tumor mass ;
  • -Unresectable tumor;
  • -Finished chemotherapy treatment with Gemcitabine and Cisplatin, preferably 8 cycles; If less cycles are given, patients are still eligible for this study.
  • -T1-T4 (AJCC staging 7th edition), before chemotherapy;
  • -N0-N1 (AJCC staging 7th edition), radiologically or pathologically suspect, before chemotherapy;
  • -Measurable disease to be selected as a target on CT/MRI-scan, according to RECIST criteria, after chemotherapy within 6 weeks prior to inclusion
  • -Tumor visibility on CT;
  • -If liver cirrhosis is present, it should be well compensated, with Child-Pugh grade A;
  • -Age * 18 years;
  • -ECOG performance status 0-1;
  • -Bilirubin *1.5 times normal value, AST/ALT *5 times ULN, within 6 weeks prior to inclusion;
  • -Platelets * 50x10E9/ l, Leukocytes > 1.5x10E9/l, Hb > 6 mmol/l, within 6 weeks prior to inclusion;
  • -Written informed consent, after chemotherapy;
  • -Willing and able to comply to the follow-up schedule;
  • -Able to start SBRT within 12 weeks after completion of chemotherapy.

排除标准

  • -Eligibility for resection;
  • -Prior surgery or transplantation;
  • -Multifocal tumor;
  • -Tumor extension in stomach, colon, duodenum, pancreas or abdominal wall;
  • -N2, (AJCC staging 7th edition), radiologically or pathologically suspect, before chemotherapy;
  • -Distant metastases;
  • -Progression (local or distant) during or after chemotherapy
  • -Previous radiotherapy to the liver;
  • -Current pregnancy

研究者

相似试验